Sensitization of operant behavior to oral cocaine with increasing- and repetitive-dose regimens

Behavioural Pharmacology

Volumn 10, Issue 1, 1999, Pages 15-26

  Lobarinas, E ^a   Lau, C E ^a   Falk, J L ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Behavioral tolerance; Cocaine; Cumulative dosing; DRL schedule; Oral drug; Sensitization

Indexed keywords

CENTRAL STIMULANT AGENT; COCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INSTRUMENTAL CONDITIONING; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; REINFORCEMENT; RESPONSE TIME; SENSITIZATION;

EID: 0032969586     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199902000-00002     Document Type: Article

References (48)

1. Allen CJ (1988). The Hold Life Has: Coca and Cultural Identity in an Andean Community. Washington, DC: Smithsonian Institute.
2. Balcells-Olivero M, Richards JB, Seiden LS (1997). Sensitization to amphetamine on the differential-reinforcement-of-low-rate 72-s schedule. Psychopharmacology 133:207-213.
3. Bedford JA, Lovell DK, Turner CE, Elsolly MA, Wilson MC (1980). The anorexic and actometric effects of cocaine and two coca extracts. Pharmacol Biochem Behav 13:403-408.
4. Borowsky B, Kuhn CM (1991). Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res 543:301-306.
5. Bowen SE, Fowler SC, Kallman MJ (1993). Effects of variation in chronic dose of cocaine on contingent tolerance as assessed in a milk-drinking task. Psychopharmacology 113:67-75.
6. Daunais JB, McGinty JF (1995). Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Mol Brain Res 29:201-210.
7. Dow-Edwards D, Fico TA, Osman M, Gamagaris Z, Hutchins DE (1989). Comparison of oral and subcutaneous routes of cocaine administration on behavior, plasma drug concentration and toxicity in female rats. Pharmacol Biochem Behav 33:167-173.
8. Emmett-Oglesby MW (1995). Sensitization and tolerance to the motivational and subjective effects of psychostimulants. In: The Neurobiology of Cocaine: Cellular and Molecular Mechanisms. RP Hammer Jr RP, (editors). New York: CRC Press, pp. 31-47.
9. Falk JL, Ma F, Lau CE (1991). Chronic oral cocaine self-administration pharmacokinetics and effect on spontaneous and discriminative motor functions. J Pharmacol Exp Ther 257:457-465.
10. Favier R, Caceres E, Guillon L, Sempore B, Sauvain M, Koubi H, Spielvogel H (1996). Coca chewing for exercise: hormonal and metabolic responses of nonhabitual chewers. J Appl Physiol 81:1901-1907.
11. Foltin RW, Woolverton WL. Schuster CR (1983). Effects of psychomotor stimulants, alone and in pairs, on milk drinking in the rat after intraperitoneal and intragastric administration. J Pharmacol Exp Ther 226:411-417.
12. Gawin FH (1991). Cocaine addiction: psychology and neurophysiology. Science 251:1580-1586.
13. Gawin FH, Kleber HD (1985). Cocaine abuse in a treatment population: patterns and diagnostic considerations. In: Cocaine Use in America: Epidemiologic and Clinical Perspectives Kozel NJ, Adams EH (editors), Washington DC: Govnt. Printing Office, pp. 182-193.
14. Goeders NE, Irby BD, Shuster CC, Guerin GF (1997). Tolerance and sensitization to the behavioral effects of cocaine in rats: relationship to benzodiazepine receptors. Pharmacol Biochem Behav 57:43-56.
15. Heidbreder CA, Shippenberg TS (1996). Evidence for the involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse 24:182-192.
16. Heidbreder CA, Babovic-Vuksanovic D, Shoaib M, Shippenberg TS (1995), Development of behavioral sensitization to cocaine: influence of Kappa opioid receptor agonists. J Pharmacol Exp Ther 275:150-163.
17. Hooks MS, Duffy P, Striplin C, Kalivas PW (1994). Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology 115:265-272.
18. Kilbey MM, Ellinwood, EH (1977). The effect of age-related factors on behavior induced by cocaine. Life Sci 20:1847-1854.
19. Kilbey MM, Sannerud CA (1985). Models of tolerance: Do they predict sensitization to the effects of psychomotor stimulants. In: Behavioral Pharmacology: The Current Status. Seiden LS, Balster RL (editors). New York: Liss, pp. 295-321.
20. King GR, Joyner C, Lee T, Kuhn C, Ellinwood Jr EH (1992). Intermittent and continuous cocaine administration: residual behavioral states during withdrawal. Pharmacol Biochem Behav 43:243-248.
21. Kleven MS, Woolverton WL (1996). Effects of exposure regimen on changes in sensitivity to the effects of cocaine on schedule-controlled behavior in rhesus monkeys. Behav Brain Res 79:101-107.
22. Kuribara H (1996). Effects of interdose interval on ambulatory sensitization to methamphamine, cocaine and morphine in mice. Eur J Pharmacol 316:1-5.
23. Lau CE, Imam A, Ma F, Falk JI. (1991). Acute effects of cocaine on spontaneous and discriminative motor functions: relation to route of administration and pharmacokinetics. J Pharmacol Exp Ther 257:444-456.
24. Levy AD, Li Q, Sanz MCA, Rittenhouse PA, Kerr JE, Van de Kar LD (1992). Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure. Life Sci 51:887-897.
25. Lin-Chu G, Robinson TE, Becker JB (1985). Sensitization of rotational behavior produced by a single exposure to cocaine, Pharmacol Biochem Behav 22:901-903.
26. Oliveto AH, Rosen MI, Woods SW, Kosten TR (1995). Discriminative stimulus, self-reported and cardiovasular effects of orrally administered cocaine in humans. J Pharmacol Exp Ther 272:231-241.
27. Post RM (1980), Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci 26:1275-1282.
28. Post RM, Contel NR (1983). Human and animal studies of cocaine: implications for development of behavioral pathology. In: Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. Creese I (editor). New York: Raven Press, pp. 169-203.
29. Reith MEA, Benuck M, Lajtha A (1987). Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J Pharmacol Exp Ther 243:281-287.
30. Schenk S, Davidson ES (1998). Stimulant preexposure sensitizes rats and humans to the rewarding effects of cocaine. In: Laboratory Behavioral Studies of Vulnerability to Drug Abuse. Wetherington CL, Falk JL (editors). NIDA Research Monograph 169, Washington, DC: Government. Printing Press. pp. 56-82.
31. Schenk S, Partridge B (1997). Sensitization and tolerance in psychostimulant self-administration. Pharmacol Biochem Behav 57:543-550.
32. Schindler CW, Wu X-Z, Su T-P, Goldberg SR, Katz JL (1990). Enhanced sensitivity to behavioral effects of naltrexone in rats, J Pharmacol Exp Ther 252:8-14.
33. Schuster CR, Dockens WS, Woods JH (1966). Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacology Berl 9:170-182.
34. Segal DS, Kuczenski R (1997). Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behav Brain Res 88:251-260.
35. Seidman MH, Lau CE, Chen R, Falk JL (1992). Orally self-administered cocaine: reinforcing efficacy by the place preference method. Pharmacol Biochem Behav, 43:235-241.
36. Spielvogel H, Rodriguez, Sempore B, Caceres E, Cottet-Emard J-M, Guillon L, Favier R (1997). Body fluid homeostasis and cardiovascular adjustments during submaximal exercise: influence of chewing coca leaves. Eur J Appl Physiol 75:400-406.
37. Stewart J, Badiani A (1993). Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4:289-312.
38. Stripling JS, Ellinwood Jr EH (1976). Cocaine: physiological and behavioral effects of acute and chronic administration. In: Cocaine: Chemical, Biological, Clinical, Social and Treatment Aspects. Mulé SJ (editor), pp. 167-185.
39. Tella SR, Schindler CW, Goldberg SR (1991). Rapid sensitization to the cardiovascular effects of cocaine in rats. Eur J Pharmacol 194:119-122.
40. Unterwald EM, Ho A, Rubenfeld JM, Kreek MJ (1994). Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J Pharmacol Exp Ther 270:1387-1397.
41. Van Dyke C, Jatlow P, Ungerer J, Barash PG. Byck R (1978). Oral cocaine: plasma concentration and central effects. Science 200:211-213.
42. Vee GL, Fink GB, Constantine GH Jr (1983). Anorexic activity of cocaine and coca extract in naïve and cocaine tolerant rats. Pharmacol Biochem Behav 18:515-517.
43. Walker DJ, Branch MN (1998). Response suppression during cumulative dosing: a role for Pavlovian conditioning. Behav Pharmacol 9:255-271.
44. Ward AS, Hancy M, Fischman MW, Folin RW (1997). Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology 132:375-381.
45. Wenger GR, Wright DW (1990). Behavioral effects of cocaine and its interaction with d-amphetamine and morphine in rats. Pharmacol Biochem Behav 35:595-600.
46. Wise RA, Bozarth MA (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
47. Woolverton WL, Kandel D, Schuster CR (1978a). Effects of repeated administration of cocaine on schedule-controlled behavior of rats. Pharmacol Biochem Behav 9:327-337.
48. Woolverton WL, Kandel D, Schuster CR (1978b). Tolerance and cross-tolerance to cocaine and d-amphetamine. J Pharmacol Exp Ther 205:525-535.